The AHA today joined physician and other groups urging CMS to take steps to ensure COVID-19 does not derail the Alternative Payment Model and value movement. Specifically, the groups urged CMS to “allow flexibility with existing deadlines and requirements and take steps to ensure clinicians are not inappropriately penalized for the extreme costs of handling the pandemic so that they can continue to focus their energy on patient care.”

In a separate letter, AHA and other groups urged House and Senate leaders to “preclude the financial impact or shared loss repayment for all accountable care organizations and other value-based program participants based on costs accrued related to COVID-19 care and during this public health crisis.” 
 

Related News Articles

Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate…
Headline
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation…
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law…
Headline
The AHA May 9 urged the Department of Health and Human Services to deny drug companies’ requests to approve their unlawful 340B rebate models. “The 340B…
Headline
The House Ways and Means Committee today advanced its portion of the fiscal year 2025 reconciliation bill by a 26-19 vote along party lines, following an hours…
Headline
The House Ways and Means Committee May 13 began to mark up its portion of the fiscal year 2025 reconciliation bill, with some proposals impacting the health…